News Focus
News Focus
icon url

DewDiligence

01/19/22 2:06 PM

#241241 RE: dewophile #241240

Thanks. Yet another question: Why are the incentives for the prescribers materially different in the two indications in question?

I get the advantage of Myfembree's FDC formulation. Wonder how ABBV will counter-detail on that aspect.